This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Young JB et al. (2003) Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA 289: 2685–2694
Wilkoff BL (2003) Dual Chamber and VVI Implantable Defibrillator trial investigators. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials. Card Electrophysiol Rev 7: 468–472
Linde C et al. (1999) Placebo effect of pacemaker implantation in obstructive hypertrophic cardiomyopathy. PIC Study Group. Pacing In Cardiomyopathy. Am J Cardiol 83: 903–907
Acknowledgements
The synopsis was written by Hannah Camm, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
D Reynolds is a consultant, investigator, stockholder and speaker for Medtronic Inc. and also a speaker for the Guidant Corporation.
Rights and permissions
About this article
Cite this article
Reynolds, D. What factors predict pacemaker syndrome and how can it be treated in patients with sinus node dysfunction?. Nat Rev Cardiol 1, 72–73 (2004). https://doi.org/10.1038/ncpcardio0040
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpcardio0040